TNDM — Tandem Diabetes Care Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual cashflow statement for Tandem Diabetes Care, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-24.8	-34.4	15.6	-94.6	-223
Depreciation
Deferred Taxes
Non-Cash Items	72.9	87.3	67.6	135	193
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-12.3	-36.6	14.4	-4.65	-17.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	41.9	24.7	111	50.5	-31.8
Capital Expenditures	-19.5	-32.3	-23.5	-43	-51.6
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-37.4	-264	-163	76.1	-34.1
Acquisition of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities	-57	-296	-187	33.2	-85.7
Financing Cash Flow Items	—	—	—	-0.675	-0.071
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	24.2	314	51.9	16.9	4.11
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	9.35	43.4	-23.4	101	-114